Long-Term Effects of Varying Alcohol Dosing in Percutaneous Septal Ablation for Obstructive Hypertrophic Cardiomyopathy: A Randomized Study With a Follow-up up to 11 Years by Veselka, Josef, MD, PhD, Tomašov, Pavol, MD, Zemánek, David, MD

Get full text

Survival of Patients ≤ 50 Years of Age After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy by Veselka, Josef, MD, PhD, Krejčí, Jan, MD, PhD, Tomašov, Pavol, MD, Jahnlová, Denisa, MD, Honěk, Tomáš, MD, Januška, Jaroslav, MD, Branny, Marian, MD, Zemánek, David, MD, PhD

Get full text

Effect of Rosuvastatin Therapy on Troponin I Release Following Percutaneous Coronary Intervention in Nonemergency Patients (from the TIP 3 Study) by Veselka, Josef, MD, PhD, Hájek, Petr, MD, Tomašov, Pavol, MD, Tesař, David, MD, PhD, Brůhová, Hana, MD, Matějovič, Martin, MD, PhD, Branny, Marian, MD, Studenčan, Martin, MD, PhD, Zemánek, David, MD, PhD

Get full text

Risk and Causes of Death in Patients After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy by Veselka, Josef, MD, PhD, Zemánek, David, MD, PhD, Jahnlová, Denisa, MD, Krejčí, Jan, MD, PhD, Januška, Jaroslav, MD, Dabrowski, Maciej, MD, PhD, Bartel, Thomas, MD, Tomašov, Pavol, MD

Get full text

Effect of Two-Day Atorvastatin Pretreatment on the Incidence of Periprocedural Myocardial Infarction Following Elective Percutaneous Coronary Intervention: A Single-Center, Prospec... by Veselka, Josef, MD, PhD, Zemánek, David, MD, Hájek, Petr, MD, Malý, Martin, MD, PhD, Adlová, Radka, MD, Martinkovičová, Lucie, MD, PhD, Tesař, David, MD, PhD

Get full text

Effect of Two-Day Atorvastatin Pretreatment on Long-Term Outcome of Patients With Stable Angina Pectoris Undergoing Elective Percutaneous Coronary Intervention by Veselka, Josef, MD, PhD, Zemánek, David, MD, Hájek, Petr, MD, Malý, Martin, MD, PhD, Adlová, Radka, MD, Martinkovičová, Lucie, MD, Tomašov, Pavol, MD, Tesař, David, MD, PhD

Get full text

Low Incidence of Procedure-Related Major Adverse Cardiac Events After Alcohol Septal Ablation for Symptomatic Hypertrophic Obstructive Cardiomyopathy by Veselka, Josef, MD, PhD, Lawrenz, Thorsten, MD, Stellbrink, Christoph, MD, Zemanek, David, MD, PhD, Branny, Marian, MD, Januska, Jaroslav, MD, Groch, Ladislav, MD, PhD, Dimitrow, Pawel, MD, PhD, Krejci, Jan, MD, PhD, Dabrowski, Maciej, MD, Mizera, Stanislav, MD, Kuhn, Horst, MD

Get full text

Interventional left atrial appendage closure vs. novel anticoagulation agents in atrial fibrillation patients indicated for long term anti-coagulation (PRAGUE-17 study) by Osmancik, Pavel, MD, PhD, Tousek, Petr, MD, PhD, Herman, Dalibor, MD, PhD, Neuzil, Petr, MD, CSc, Hala, Pavel, MD, Stasek, Josef, MD, PhD, Haman, Ludek, MD, PhD, Kala, Petr, MD, PhD, Poloczek, Martin, MD, Branny, Marian, MD, PhD, Chovancik, Jan, MD, Cervinka, Pavel, MD, PhD, Holy, Jiri, MD, Vancura, Vlastimil, MD, PhD, Rokyta, Richard, MD, PhD, Taborsky, Milos, MD, CSc, Kovarnik, Tomas, MD, PhD, Zemanek, David, MD, PhD, Peichl, Petr, MD, PhD, Haskova, Sarka, Eng, Jarkovsky, Jiri, Eng, Widimsky, Petr, MD, DrSc

Get full text

Early Opening of Dormant Septal Collaterals During Alcohol Septal Ablation: A Possible Hazard of Remote Necrosis by Spacek, Miloslav, MD, Zemanek, David, MD, PhD, Tomasov, Pavol, MD, Veselka, Josef, MD, PhD

Get full text

Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial by Weisz, Giora, Dr, Généreux, Philippe, MD, Iñiguez, Andres, MD, Zurakowski, Aleksander, MD, Shechter, Michael, MD, Alexander, Karen P, Prof, Dressler, Ovidiu, MD, Osmukhina, Anna, PhD, James, Stefan, Prof, Ohman, E Magnus, Prof, Ben-Yehuda, Ori, MD, Farzaneh-Far, Ramin, MD, Stone, Gregg W, Prof

Get full text

Properties of Combined Beam and Plate for High-Strength Steels and Titanium by Zemanek,Stephen F, Nappi,Natale S

Request full text